Navigation Links
Komen for the Cure Central New Mexico Affiliate, Lt. Gov. Diane Denish, Sen. Dede Feldman, Breast Cancer Survivors Call on Elected Officials to 'Close the Gap' in Access to Breast Health Services
Date:11/20/2007

Interviews available with:

-- Meghan Evett, public policy manager with Susan G. Komen for

the Cure

-- Kathy Anderson with the Central New Mexico Affiliate of

Komen for the Cure

-- Jennifer Hawthorne, breast cancer survivor, of the Navajo

Nation

WHEN: Nov. 28 from noon to 2:00 p.m.

WHERE: National Hispanic Cultural Center at 1701 4th Street SW

Night at the PIT

Komen for the Cure is sponsoring the UNM v. Southern Utah game, and will light up The Pit in pink with basketballs, foam fingers, T-shirts, breast health materials and Promise Ring giveaways. Komen advocates will educate Lobo fans on breast health issues and how they can join the breast cancer movement.

WHAT: Komen Night at The Pit

WHO: Policy leaders, scientists, health professionals, breast cancer

survivors, cheerleaders, sportscasters and Komen for the Cure

advocates

WHEN: Nov. 28 at 7:00 p.m.

WHERE: University of New Mexico PIT


'/>"/>
SOURCE Susan G. Komen for the Cure
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. In Celebration of Breast Cancer Awareness Month, Susan G. Komen for the Cure San Diego Announces Opportunities for San Diegans to Get Involved in the Fight Against Breast Cancer
2. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
3. Forbes Honors Susan G. Komen for the Cure Founder as Trailblazer
4. Celebrities Pledge to Wear Pink, End Breast Cancer Forever With Susan G. Komen for the Cure
5. PNY Technologies and Susan G. Komen for the Cure Partner to Raise Awareness of Breast Cancer
6. Komen for the Cure Launches Presidential Campaign
7. Susan G. Komen for the Cure Partners With the Original Butter Bell(R) Crock Developer
8. Susan G. Komen for the Cures Phoenix Affiliate, State Officials, Survivors and Advocates Call for Action on Breast Cancer
9. Susan G. Komen for the Cure Launches Unprecedented Global Expansion Program in 10 Countries
10. Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board
11. HSN Is Seeing Pink with Susan G. Komen for the Cure During National Breast Cancer Awareness Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2008)...fix without losing taste, experts say , ,...t healthier this holiday season by altering recipe...he Texas AgriLife Extension Service. , Holiday...f almost any holiday recipe without a noticeable d...amowicz said in a news release. , "If a recipe...
(Date:11/21/2008)...ether to stop abusive behavior, experts say , ...or that was once dismissed as "kids being kids" is...research shows the negative effects on both the bu...chools, parents and even kids themselves are comin...vior. , "Bullying shouldn,t be considered a no...
(Date:11/21/2008)...Call/ -- Heska Corporation,(Nasdaq: HSKA ) toda...y of,Security Analysts, 12th Annual Biotech and S... 1177 Avenue of the Americas, 2nd Floor in New Yor...9:35 a.m. Eastern Time (7:35 a.m.,Mountain Time) ... weeks,following the presentation through a link ...
(Date:11/21/2008)...nique to combat cancer, study says, , ...earchers have discovered that some cancer cells us...might lead to new treatments that starve and kill ...cells in the body need to produce energy. They do ...quires oxygen. Compared with normal cells, tumor c...
Breaking Medicine News(10 mins):Health News:Substitutions Make Holiday Fare Healthier 2Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3Health News:New Approach Keeps Tumor Cells From Refueling 2
...he director general of the Uganda AIDS Commission,...y hamper patients’ reach of anti-retroviral drugs/...es. Presently almost 75,000 patients are using the...augment the annual healthcare budget over the year...
...to fight against bird flu was developed by Peter P...nai School of Medicine in New York City//. He said...g of birds. It is a vaccine for the poultry and it...astle disease. The team of American researchers in...
...omprising of senior doctors, members of the Scotti...re in San Francisco for up to a fortnight// at cos...tants. They are trying to recruit staff under a co...rtage of physicians. With hundreds of junior doct...
... nursing technology in India is very similar to th...anslated into the United States turning// towards ... also being rated high in the quality of training ...zing their dream of seeking greener pastures. St....
Other Medicine News:Health News:Plans Of Recruiting Pas From America Causes Displeasure In Scotland 2Health News:Plans Of Recruiting Pas From America Causes Displeasure In Scotland 3
(Date:11/20/2008)...IA, Nov. 20 GlaxoSmithKli...States Food and Drug Administration (FDA) granted ... for the treatment of thrombocytopenia in patients... purpura (ITP) who have had an insufficient respon...omy. The approval is a significant milestone for P...
(Date:11/20/2008)... 20 Arpida (SWX:,ARPN) ...sory Committee of the,U.S. Food and Drug Administ...al of intravenous iclaprim, an antibiotic currentl...th complicated skin and skin structure infections,...esistant Staphylococcus,aureus (MRSA). , A...
(Date:11/20/2008)...swire-FirstCall/ -- Bionovo, Inc.,(Nasdaq: BNVI... the Phase 1B,clinical trial of their lead drug c...ZL101, at the Society for Integrative Oncology,s F.... The Company,s oral presentation was selected,a...a part of the Best of the,SIO Session on November...
(Date:11/20/2008)...ire/ -- Radius Health ("Radius") announced today t... second institutional financing round, increasing ... total amount raised since the company,s inception...estors participated in the financing, led by MPM B..., The Wellcome Trust, HealthCare Ventures, Oxford ...
Breaking Medicine Technology:FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2SAFC Pharma to Increase Viral Product Manufacturing Capacity 2583 1SAFC Pharma to Increase Viral Product Manufacturing Capacity 2583 2SAFC Pharma to Increase Viral Product Manufacturing Capacity 2583 3AMEX Notifies Signalife that It Will Need to Comply with Minimum Stockholders Equity Requirement 2580 1AMEX Notifies Signalife that It Will Need to Comply with Minimum Stockholders Equity Requirement 2580 2AMEX Notifies Signalife that It Will Need to Comply with Minimum Stockholders Equity Requirement 2580 3Black Americans Still Wary of Clinical Trials 9519 1Black Americans Still Wary of Clinical Trials 9519 2Black Americans Still Wary of Clinical Trials 9519 3Black Americans Still Wary of Clinical Trials 9519 4Cholesterol Drug Zetia Doesnt Cut Heart Attack Risk 3A Study 9516 1Cholesterol Drug Zetia Doesnt Cut Heart Attack Risk 3A Study 9516 2Cholesterol Drug Zetia Doesnt Cut Heart Attack Risk 3A Study 9516 3
...ccine could offer protection,for infants against ...isease , , TORONTO, Canada, May 11, , 2007 ...rom a,Phase II vaccine clinical study presented th... (PAS) Annual Meeting in,Toronto, Canada. The new ... vaccine holds potential to protect infants in the...
...SINESS WIRE)--May 14, 2007 - BioDelivery,Sciences ...ional,statistically significant results with BEMA ... in its Phase III efficacy clinical,trial for the ...inuing analysis of the,secondary efficacy endpoint... SPID 15 (Summary of Pain Intensity Difference at,...
Other Medicine Technology:GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 2GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 3GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 4GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 5BDSI Announces Positive Key Secondary Efficacy Endpoint Results for,Bema Fentanyl 2BDSI Announces Positive Key Secondary Efficacy Endpoint Results for,Bema Fentanyl 3BDSI Announces Positive Key Secondary Efficacy Endpoint Results for,Bema Fentanyl 4
...iol (E2) is the most potent, naturally secreted es...vary [1]. In the ovary, estradiol is produced from...nt estrogen derived from androstenedione. Estrone ...ues. In men, small amounts of estradiol are produc...
Innotrac Aio! 2nd generation cardiac troponin I assay is a highly sensitive immunoassay providing quantitative results directly from whole blood in less than 18 minutes. The assay is based on a uniqu
...TROS ECi brings true automation and continuous ran...g. Highly sensitive assays for thyroid, anemia, ca...one metabolism testing are currently available, wi...e VITROS ECi can simultaneously process 60 accessi...
...TE 2500 is a high-throughput immunoassay system bu...IMMULITE 2000 with the important addition of Logic... assays to be designed for optimal performance wit...llows for critical assays such as the cardiac biom...
Medicine Products: